About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04600193

a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients

Hyperphosphatemia is a common problem among patientens suffering from chronic kidney disease. Hyperphosphatemia is associated with increased risk of cardiovascular diseases. One of the treatments are ...

Lead sponsor: University of Copenhagen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jens Rikardt Andersen, MD

CONTACT

+4523346652 [email protected]

Stine Rikardt Kristensen

CONTACT

+4528967003 [email protected]

Sponsors

Lead Sponsor

University of Copenhagen

Collaborators

Stine Kristensen
Gita Krüger Mørch
Rizwan Butt
Ditte Hansen

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients \> 18 years
•Competent
•The patient should be able to take a sample of p-fluid and urine by himself
•Chronic peritoneal dialysis
•Reads and understand danish
•Has been informed written and oraly about the study and signed informed consent
•P-phosphate koncentrations 0,7-2,0 .mol/l
•P - ioniset calcium 1,1-1,4 mmol/l

Exclusion Criteria

•Pregnant or breast-feeding
•Terminal patients
•If the experience acute infections or other acute situations they will be excluded from the study

Related studies

DIALysis With EXpanded Solute Removal

NCT06660277 · Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD), and more

Smart and Fit for Kidney Transplantation

NCT06040281 · Chronic Kidney Disease Requiring Chronic Dialysis

Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients

NCT06873880 · Chronic Kidney Disease Requiring Chronic Dialysis

Fluid Intake After Hemodialysis

NCT04721652 · Chronic Kidney Disease Requiring Chronic Dialysis, Interdialytic Weight Gain

RECRUITINGPhase 2

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

NCT06225544 · Haemodialysis, Chronic Kidney Disease Requiring Chronic Dialysis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 18, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment21

Start dateMar 2021

Last updatedMar 18, 2021

Condition

Chronic Kidney Disease Requiring Chronic Dialysis

Locations shown

Herlev Hospital

Herlev

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 18, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions